BALZER THOMAS enters LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC. with 255.32K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/1/2026ACC: 0001213900-26-051054
Officer· Chief Medical Officer
Since Apr 2026
255.32K
Baseline shares
100% direct
255.32K
Direct ownership
1 position
299.49K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock; $0.0001 par value
DirectShares owned255.32K
Total
255.32K direct255.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock; $0.0001 par value | 255.32K | Direct |
| Total | 255.32K | 255.32K direct |
Derivative Holdings4
Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
50.68K
Shares owned
N/A
Exercise price
2.13
Expiration
—
Exercise window
—
Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
33.78K
Shares owned
N/A
Exercise price
2.13
Expiration
—
Exercise window
—
Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
46.12K
Shares owned
N/A
Exercise price
2.13
Expiration
—
Exercise window
—
Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
168.92K
Shares owned
N/A
Exercise price
2.31
Expiration
—
Exercise window
—
Total
Underlying
299.49K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Common Stock | 2.13 | — | — | 50.68K | N/A |
| Option (right to buy) Direct | Common Stock | 2.13 | — | — | 33.78K | N/A |
| Option (right to buy) Direct | Common Stock | 2.13 | — | — | 46.12K | N/A |
| Option (right to buy) Direct | Common Stock | 2.31 | — | — | 168.92K | N/A |
| Total | 299.49K | 0.00 | ||||